PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

BACKGROUND: Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacokinetics (PK) should be dependent upon CHDF conditions. Although the antibiotic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Health Care Sci
Hlavní autoři: Akashita, Gaku, Hosaka, Yuto, Noda, Toru, Isoda, Kazuya, Shimada, Tsutomu, Sawamoto, Kazuki, Miyamoto, Ken-ichi, Taniguchi, Takumi, Sai, Yoshimichi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://ncbi.nlm.nih.gov/pubmed/26819742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-015-0031-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky